The Big Data Blog

Melhem Scientific proudly announces the appointment of Dr. Bakhos Tannous as Chair of the Board of Advisors, marking a pivotal milestone in the organization’s global scientific mission. Dr. Tannous is an internationally renowned scientist, educator, and visionary leader in biomedical research, particularly in cancer and brain tumor therapeutics. With over 150 peer-reviewed publications and review articles, he has built a distinctive legacy in advancing multidisciplinary teams

FOR IMMEDIATE RELEASE Melhem Scientific President Nehme G. Melhem Officially Invited to Join the Forbes Business Council Washington DC, United States — November 4, 2025 — Melhem Scientific is proud to announce that its President, Nehme G. Melhem, has been officially invited and enlisted into the Forbes Business Council, a premier international community recognized for leadership excellence, business innovation, and meaningful global impact. The invitation reflects Mr. Melhem’

FOR IMMEDIATE RELEASE Washington, D.C., October 28, 2025 -- Melhem Scientific proudly announces the establishment of its newest division, the Department of Artificial Intelligence and Global Health Informatics , a pioneering step in integrating artificial intelligence and advanced informatics into global medical and research practices. The new department will serve as a hub for innovation, bridging medicine, data science, and technology to develop intelligent systems that imp

Melhem Scientific announced the establishment of the Celina Fund, a new initiative dedicated to advancing cancer research and supporting the next generation of nurses.

The new foundation will focus on arts and culture, environmental sustainability, and humanitarian support to strengthen human dignity and global well-being.

From Boston and Washington, D.C. to Beirut, Melhem Scientific advances its mission to foster research, education, and public health collaborations.

Melhem Scientific’s $1.2M commitment to advancing gene editing and aging research. We’re investing in the future of CRISPR innovation to unlock breakthroughs in age-related disease treatment.

For years, Mr. Nehme Gerges Melhem, president of Melhem Scientific, poured his efforts into the American Lebanese Awareness Association...